Invesaro

Stocks SOPAQ Financial statements

Financial statements

SOCIETY PASS INCORPORATED. financial statements

Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data SOCIETY PASS INCORPORATED. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2021FY2021FY2022FY2023FY2024
Revenue0.050.525.648.177.11
Cost of revenue0.090.714.675.75.24
Gross profit-0.04-0.190.972.471.86
Research and development0.170.10.070.060.05
Selling and marketing00.3310.580.34
General and administrative3.5333.430.619.810.8
Operating expenses3.713435.120.411.2
Operating income-3.75-34.2-34.2-18-9.32
Interest expense0.050.040.0300.15
Interest income0.080.160.01
Other non-operating income-0.07-0.640.14-0.11-0.84
Pre-tax income-3.82-34.9-34-18.1-10.2
Income tax0.010.0100.030.08
Net income to minority interests-0.1-0.230.04-0.01
Net income-3.83-34.9-33.8-18.1-10.2
EBITDA-2.94-31-30.8-16.7-8.67
EPS, basic-8.35-54.85-20.57-9.39-3.45
EPS, diluted-8.35-54.85-20.57-9.39-3.45
Shares, basic (weighted)0.470.631.641.932.96
Shares, diluted (weighted)0.470.631.641.932.96

Balance sheet

FY2021FY2021FY2022FY2023FY2024
Cash and equivalents0.5123.318.93.637.63
Receivables00.050.951.341.11
Inventory00.220.310.430.16
Other current assets2.215.19
Total current assets0.5729.6237.9514.5
Property, plant and equipment0.020.060.710.690.41
Lease right-of-use assets0.080.631.541.410.75
Goodwill2.770.090.08
Intangible assets7.247.466.085.5
Total assets7.8735.232.716.421.3
Accounts payable0.050.261.31.693
Accrued liabilities0.480.758.288.560.05
Deferred revenue0.020.031.411.271.43
Short-term debt0.03
Total current liabilities2.992.4411.610.423.2
Lease liabilities0.050.411.070.850.39
Total liabilities18.32.8512.711.323.7
Paid-in capital2.2379.8101106108
Retained earnings-12.6-47.4-81.1-99.3-110
Treasury stock-0.79-0.05
Other comprehensive income-0.06-0.050.06-0.240.27
Shareholders' equity-10.432.420.35.31-2.14
Minority interests-0.1-0.34-0.28-0.27
Total equity-10.432.3205.03-2.41
Total liabilities and equity7.8735.232.716.421.3
Shares outstanding0.51.321.822.223.72

Cash flow statement

FY2021FY2021FY2022FY2023FY2024
Net income-3.83-34.9-34-18.1-10.2
Depreciation and amortization0.813.213.311.270.65
Stock-based compensation2.898.33.970.8
Deferred income tax-0.150.09
Change in receivables0.01-0.050.17-0.170
Change in inventory-0.01-0.22-0.090.550.18
Change in payables00.21-0.860.411.46
Cash from operations-1.25-10.8-14.5-13.92.47
Capital expenditures-0.05-0.57-0.22-0.03
Acquisitions-0.08
Purchases of investments-0.2
Cash from investing-0.250.18-0.34-0.03
Debt repaid-0.63-0.8
Stock issued11.5
Share buybacks-0.79
Cash from financing1.2133.810.2-0.791.48
Exchange rate effect-0.06-0-0.17-0.250.04
Net change in cash-0.122.8-4.26-15.33.96
Free cash flow-10.9-15-14.12.44
Interest paid000.15
Income taxes paid0.010.04

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2025; growth uses fiscal years. Valuation uses the share price of $0.00 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin45.7%Gross profit / revenue.
Operating margin-143.4%Operating income / revenue.
EBITDA margin-137.8%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-146.1%Pre-tax income / revenue.
Net margin-146.0%Net income / revenue.
Operating cash flow margin-261.1%Cash from operations / revenue.
Return on equity (ROE)-75.9%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-32.0%Net income / average total assets.
Return on invested capital (ROIC)-111.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue0.7%Research and development expense / revenue.
D&A / revenue5.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-13.0%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y139.1%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y-24.6%Gross profit vs the same period a year earlier. Only from a positive base.
Book value growth, 1y-140.3%Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y30.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-15.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y53.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y67.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.40xCurrent assets / current liabilities.
Quick ratio0.42x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.35x(Cash + short-term investments) / current liabilities.
Liabilities / assets59.5%Total liabilities / total assets.
Interest coverage-92.2xOperating income / interest expense.
Working capital$7.7MCurrent assets - current liabilities.
Goodwill and intangibles / assets15.5%(Goodwill + intangible assets) / total assets.
Tangible book value$8.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.22xRevenue / average total assets.
Fixed asset turnover21.1xRevenue / average property, plant and equipment.
Inventory turnover47.7xCost of revenue / average inventory.
Days inventory8 days365 x average inventory / cost of revenue.
Receivables turnover5.40xRevenue / average receivables.
Days sales outstanding68 days365 x average receivables / revenue.
Days payables317 days365 x average accounts payable / cost of revenue.
Cash conversion cycle-242 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$1.84Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$1.26Revenue / diluted weighted shares.
Operating cash flow per share-$3.29Cash from operations / diluted weighted shares.
Book value per share$2.28Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$1.44Tangible book value / shares outstanding.
Cash per share$1.07(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$1.2KShare price x shares outstanding.
Enterprise value-$6.6MMarket cap + total debt - cash - short-term investments.
P/S0.00xMarket cap / revenue.
P/B0.00xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book0.00xMarket cap / tangible book value, when positive.
Earnings yield-864,226.0%Net income / market cap (the inverse of P/E).
What was SOCIETY PASS INCORPORATED.'s revenue in fiscal 2024?

SOCIETY PASS INCORPORATED. reported revenue of $7.1M for fiscal 2024, 13% lower than the year before.

Was SOCIETY PASS INCORPORATED. profitable in fiscal 2024?

No. It reported a net loss of $10.2M.

How much free cash flow did SOCIETY PASS INCORPORATED. generate in fiscal 2024?

Cash from operations of $2.5M minus capital expenditures of $30.0K left free cash flow of $2.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SOCIETY PASS INCORPORATED.